NCT06400888

Needle-Free Subcutaneous Injector and Conventional Intramuscular Injection of Mecobalamin in Diabetes Peripheral Neuropathy

a Prospective, Randomized, Open-Label, Clinical Trial Study Comparing the Efficacy and Safety for Needle-Free Subcutaneous Injector and Conventional Intramuscular Injection of Mecobalamin in Diabetes Peripheral Neuropathy

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Peking University Third Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The evaluation for efficacy and safety of needle-free subcutaneous injector and conventional intramuscular injection of mecobalamin for diabetic neuropathy.

Conditions

• Diabetic Peripheral Neuropathy

Interventions

Type	Name	Description
OTHER	needle-free subcutaneous injector for Mecbl	needle-free subcutaneous injector for Mecbl
OTHER	intramuscular injection of Mecbl	intramuscular injection of Mecbl

Timeline

• Start date: 2024-05-30
• Primary completion: 2024-12-31
• Completion: 2025-12-31
• First posted: 2024-05-06
• Last updated: 2024-05-06